Results 221 to 230 of about 2,242,574 (332)

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

Antisense RNA regulates glutamine synthetase in a heterocyst-forming cyanobacterium. [PDF]

open access: yesPlant Physiol
Álvarez-Escribano I   +4 more
europepmc   +1 more source

The genetic architecture of epilepsy across molecular mechanisms and clinical heterogeneity

open access: yesEpilepsia Open, EarlyView.
Abstract Epilepsy comprises a highly heterogeneous group of neurological disorders unified by a persistent predisposition to recurrent seizures, yet driven by remarkably diverse genetic, molecular, and network‐level mechanisms. Advances in genomic technologies have revealed that epilepsy arises from a multilayered genetic architecture encompassing rare
Mohammad Reza Seyedtaghia   +4 more
wiley   +1 more source

Inhibition of gene expression in plant cells by expression of antisense RNA.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1986
Joseph R. Ecker, Ronald W. Davis
semanticscholar   +1 more source

The IS10 transposase mRNA is destabilized during antisense RNA control.

open access: yesEMBO Journal, 1990
C. Case, E. L. Simons, Robert W. Simons
semanticscholar   +1 more source

World of Antisense RNA

open access: yesJapanese Journal of Clinical Chemistry, 2005
Funato, Tadao   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy